Immune-checkpoint inhibitor resistance in patients with cancer
The introduction of immune checkpoint inhibitors (ICIs) has transformed the landscape of oncology, offering significant improvements in patient survival and achieving remarkable long-term outcomes. Despite these advances, the therapeutic benefits of ICIs are not universal, and existing biomarkers of...
Saved in:
| Main Authors: | Luis Cabezón-Gutiérrez, Sara Custodio-Cabello, Magda Palka-Kotlowska, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-05-01
|
| Series: | Exploration of Immunology |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1003196/1003196.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic mechanisms of immunotherapy resistance
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-03-01) -
Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01) -
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01) -
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01) -
Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors
by: Jiyuan Yang, et al.
Published: (2025-08-01)